Results 211 to 220 of about 131,451 (349)

Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma

ImmunoTargets and Therapy
Honghui Xie,1– 3,* Lin Zhang,1,3,4,* Lizhi Chen,5,* Wenchao Zhou,1,6 Lijuan Zhang,1,3 Yong Su,1– 3 Bocheng Li,1,6 Peng Ding,1,6 Yun Xiao,1– 3 Tianzhu Lu,1,2,4,7 Xiaochang Gong,1,2,4,7 Jingao Li1,2,4,7 1NHC Key Laboratory of ...
Xie H, Zhang L, Chen L, Zhou W, Zhang L, Su Y, Li B, Ding P, Xiao Y, Lu T, Gong X, Li J   +11 more
doaj  

Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy

Cancer Medicine, Volume 15, Issue 5, May 2026.
We studied 630 OPSCC patients treated with chemoradiotherapy in our institute. There was a low incidence of HPV‐associated OPSCC in our cohort. Tobacco remains the main etiological factor in our cohort. HPV status by p16 IHC, T stage, RT technique, and RT doses were independent prognostic factors for OPSCC patients.
Sheetal R. Kashid, Ashwini Budrukkar, Monali Swain, Sarbani Ghosh Laskar, Vedang Murthy, Tejpal Gupta, Ajay Sasidharan, Vijay Patil, Amit Joshi, Vanita Noronha, Neha Mittal, Manoj Mahimkar, Asawari Patil, Usha Patel, Shwetabh Sinha, Anuj Kumar, Nandini Menon, Munita Bal, Kumar Prabhash, Jai Prakash Agarwal   +19 more
wiley   +1 more source

Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel Compared to Docetaxel Plus Nedaplatin as Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis

Quanquan Sun, Jing Chen, Zhimin Ye, Yonghong Hua, Lu-Ying Liu, Tongxin Liu   +5 more
openalex   +2 more sources

Adaptive radiotherapy for nasopharyngeal carcinoma

, 2020
Jishi Li, Zhiyuan Xu, Avinash Pilar, Brian O’Sullivan, Shao Hui Huang   +4 more
openalex   +1 more source

18FDG-PET/MRI/CT fusion-guided conformal radiotherapy for nasopharyngeal and oropharyngeal carcinomas: a differential dose delivery based on functional imaging [PDF]

, 2001
Takeshi Nishioka, Hiroki Shirato, Kazuhiro Tsuchiya, Eriko Tsukamoto, Keiichi Ohomori, Akira Yamazaki, Hidefumi Aoyama, Shinta Nishioka, Kazuo Miyasaka   +8 more
openalex   +1 more source

The Clinical Relevance of Lymph Node Ratio for Post‐Mastectomy Radiotherapy in Triple‐Negative Breast Cancer: A Real‐World Analysis With Propensity Score Matching Using SEER Database

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background To define the role of post‐mastectomy radiotherapy (PMRT) in triple‐negative breast cancer (TNBC), employing lymph node ratio (LNR, ratio of positive over excised lymph nodes) to offer personalized treatment strategies for this aggressively behaving cancer type. Methods The study included a total of 6474 women diagnosed with T1‐4 N1‐
Wei‐Hong Zheng, Jia‐Yuan Sun, Jia Kou, Feng‐Yan Li, Guan‐Qiao Li, San‐Gang Wu, Zhen‐Yu He   +6 more
wiley   +1 more source

Metachronous nasopharyngeal carcinoma following sinonasal inverted papilloma - a diagnostic enigma. [PDF]

Eur Arch Otorhinolaryngol
Dosemane D, Khadilkar MN, Chandy N, Subramanian D, Rao N, Iqbal S.   +5 more
europepmc   +1 more source

The Clinical Benefits of Nutritional Supplementation Across the Chemotherapy Journey in Cancer Patients: A Multicenter Prospective Cohort Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Purpose This study aimed to explore the clinical benefits of receiving nutritional supplementation (NS) throughout the whole course of chemotherapy. Methods This multicenter prospective cohort study totally included 251 cancer patients requiring nutritional support and scheduled for chemotherapy.
Jia‐Xin Huang, Si‐Wei Xie, Hui‐Min Qu, Zhi‐Gang Feng, Xin‐Yi Wang, Jun Zhao, Quan‐Fu Li, Ying Jiang, Feng Chen, Jun Li, Shun‐Chun Yao, Ming‐Hui Zhang, Xian Shen, Xiao‐Dong Chen, Ning Li, Xi Zhang, Le Tian, Min Yang, Meng Tang, Chen‐Xin Song, Bao‐Hua Zou, Sheng‐Ling Qin, Rong Qin, Ming‐Hua Cong   +23 more
wiley   +1 more source

Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinoma. [PDF]

Transl Oncol
Huang Q, Hou T, Ren Y, Liao WX, Zhu AZ, Liu Y, Zhan XL, Yin HS.   +7 more
europepmc   +1 more source

Efficacy of Neoadjuvant Immunochemotherapy in Pulmonary Lymphoepithelioma Carcinoma Compared With Lung Squamous Cell Carcinoma and Adenocarcinoma: A Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Objective Immunotherapy has emerged as a promising treatment for patients with pulmonary lymphoepithelioma carcinoma (PLEC). This study aimed to evaluate the efficacy and safety of neoadjuvant immunochemotherapy in patients with PLEC. Methods Clinical stage IB‐III patients with PLEC who underwent neoadjuvant immunochemotherapy followed by ...
Weizhen Sun, Yaobin Lin, Yuheng Zhou, Zerui Zhao, Shoucheng Feng, Nengqi Lin, Zhichao Lin, Hao Long   +7 more
wiley   +1 more source